ANO5

Across TCGA pan-cancer cohorts, ANO5 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated ANO5 data layer compared with 26 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ANO5 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated ANO5 expression acts as an unfavorable survival marker, although some lineages such as UCEC and HNSC show a favorable association.

UCEC, HNSC, and COAD are the cancer types where ANO5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.980	0.599	<.001	32	view →
HNSC	OS	Median	All	0.940	0.350	.012	22	view →
COAD	OS	Median	IV	0.138	0.673	.002	16	view →
BRCA	OS	Median	III,IV	0.335	0.833	.011	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

ANO5–UCEC (DFS)

Open the UCEC breakdown →